Hakkında
Dr Farasat Kazmi is a Consultant Clinical Oncologist specialising in lung cancer, with particular expertise in advanced radiotherapy techniques including Stereotactic Ablative Radiotherapy (SABR). He treats lung cancer across all stages, from early-stage disease to locally advanced and metastatic cancer, using modern radiotherapy alongside chemotherapy, immunotherapy, and precision-targeted therapies guided by molecular profiling.
Dr Kazmi has a strong academic and research background and holds an MSc in Nanomedicine from the University of Oxford. He previously worked in the Early Phase Clinical Trials Unit at the Churchill Hospital, Oxford, where he was involved in first-in-human and novel targeted therapy studies. He is the Principal Investigator on three international lung cancer clinical trials and has played a leading role in Cochrane systematic reviews on genomic-guided cancer therapies, ensuring his clinical practice is firmly grounded in the highest-quality evidence.
He is actively involved in precision oncology, leading institutional initiatives focused on integrating molecular testing and personalised treatment strategies into routine cancer care. His work has been recognised through national and international awards, including competitive oncology research and education grants.
In addition to lung cancer, Dr Kazmi treats gynaecological cancers, including ovarian cancer, and non-melanoma skin cancers.
He is known for his clear communication, calm manner, and patient-centred approach, taking time to explain diagnoses and treatment options and supporting shared decision-making throughout the cancer journey.
Dr Kazmi has a strong academic and research background and holds an MSc in Nanomedicine from the University of Oxford. He previously worked in the Early Phase Clinical Trials Unit at the Churchill Hospital, Oxford, where he was involved in first-in-human and novel targeted therapy studies. He is the Principal Investigator on three international lung cancer clinical trials and has played a leading role in Cochrane systematic reviews on genomic-guided cancer therapies, ensuring his clinical practice is firmly grounded in the highest-quality evidence.
He is actively involved in precision oncology, leading institutional initiatives focused on integrating molecular testing and personalised treatment strategies into routine cancer care. His work has been recognised through national and international awards, including competitive oncology research and education grants.
In addition to lung cancer, Dr Kazmi treats gynaecological cancers, including ovarian cancer, and non-melanoma skin cancers.
He is known for his clear communication, calm manner, and patient-centred approach, taking time to explain diagnoses and treatment options and supporting shared decision-making throughout the cancer journey.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Farasat Kazmi
Eğitim ve öğretim
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Onkoloji
Kariyer ve atamalar
-
2027-09–2028-08 Junior consultant
Lisanslar ve sigorta
Tıbbi lisanslar
GB — Organización Médica Colegial de España (OMC)
Kurul sertifikaları
European Board of Onkoloji
Mesleki sorumluluk sigortası:
Generali Healthcare · 1,000,000 EUR kapsam · No claims on file
Gerçekleştirilen prosedürler
| Prosedür | Kod | Toplam sayı |
|---|---|---|
| GP consultation | 99213 | 2,383 |
| Annual physical exam | 99395 | 825 |
| Vaccination administration | 90471 | 217 |
| Minor procedure (skin) | 17110 | 230 |
Hizmetler ve fiyatlandırma
| Hizmet | Süre | Yöntem | Fiyat |
|---|---|---|---|
| New patient consultation (60m) | 60 dk | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 dk | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 dk | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 120 dk | in_clinic | 720.00 EUR |
Ofis, ekip ve uygulamada
Videolar
Araştırma ve yayınlar
h-endeksi: 5 · i10: 4
-
Long-term follow-up of Onkoloji across GB
DOI: 10.5950/euroclin.2026.0 · PMID: 31322945 · alıntılayan 39
-
Validation of clinical scoring in Onkoloji
DOI: 10.4876/euroclin.2025.1 · PMID: 36082719 · alıntılayan 165
Davetli konuşmalar
- Practical updates in Onkoloji European Annual Congress (Onkoloji) · Vienna · 2024 · invited
- Single-centre experience in Onkoloji National Society Meeting · Newmarket · 2023 · oral abstract
Ödüller ve üyelikler
Ödüller
- 🏆 Top-rated Onkoloji — Newmarket · EuroClinics Patient Choice · 2025 · regional
Topluluk üyelikleri
- WONCA Europe — Family Doctors — Member · 2028 yılından beri
- national college of family doctors — Member · 2028 yılından beri
- European Union of Medical Specialists (UEMS) — Member · 2028 yılından beri
Bu doktorun makaleleri
- Patient education Patient guide to Onkoloji
- Awareness When should you see a onkoloji?
Uluslararası hastalar için
- Koordinatör
- Patient liaison · farasat.kazmi@euroclinics.example
Konum
1 etiketHasta yorumları
Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
Son yorumlar
-
★★★★★ ✓ Doğrulanmış Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Doğrulanmış Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Doğrulanmış Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Benzer uzmanlar
Tümünü gözat →
Dr Charlotte Rees
Onkoloji · Winchester
Professor Hany Mohamad Eldeeb
Onkoloji · Milton Keynes
Professor Jonathan Ledermann
Onkoloji · London
Dr Stephen Morris
Onkoloji · London
Dr Fharat Raja
Onkoloji · London
Dr Angela Yates
Onkoloji · Brisbane
Dr Andrew Parasyn
Onkoloji · Wahroonga
Dr Mark Nathan
Onkoloji · London